Increasing evidences have indicated that CSCs contribute to NSCLC tumor initiation, malignant progression, metastasis, and therapy resistance through modulating multiple mechanism, including TGF-β/TGF-βR signaling pathway and TGF-β/TGF-βR signaling pathway [14, 15]. Here, TGFB1 is linked to neoplasm.